Androgen deprivation treatment: Does the risk of dementia increase?

被引：0
|
作者：
Alcantara-Montero, Antonio [1 ]
Sanchez-Carnerero, Clara I. [2 ]
机构：
[1] Hosp Don Benito Villanueva de la Serena, Unidad Dolor, Avda Cordoba S-N, E-06400 Don Benito, Badajoz, Spain
[2] Hosp San Pedro Alcantara, Caceres, Spain
来源：
REVISTA DE NEUROLOGIA | 2017年 / 65卷 / 10期
关键词：
PROSTATE-CANCER; THERAPY; DISEASE; TESTOSTERONE; ALZHEIMERS; MEN;
D O I：
10.33588/rn.6510.2017332
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：479 / 479
页数：1
相关论文
共 50 条
  • [21] Androgen Deprivation Therapy And Morbid Obesity: Do They Share Cardiovascular Risk Through Metabolic Syndrome?
    Cleffi, S.
    Neto, A. S.
    Reis, L. O.
    Maia, Priscila
    Fonseca, F.
    Wroclawski, M. L.
    Neves, M.
    Pompeo, A. C. L.
    Del Giglio, A.
    Faria, E. F.
    Tobias-Machado, M.
    ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (05): : 259 - 265
  • [22] No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study
    Kao, Li-Ting
    Lin, Herng-Ching
    Chung, Shiu-Dong
    Huang, Chao-Yuan
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (04) : 414 - 417
  • [23] Androgen deprivation in prostate cancer and the long-term risk of fracture
    Ojeda, S.
    Lloret, M.
    Naranjo, A.
    Deniz, F.
    Chesa, N.
    Dominguez, C.
    Lara, P. C.
    ACTAS UROLOGICAS ESPANOLAS, 2017, 41 (08): : 491 - 496
  • [24] Cardiovascullar risk with androgen deprivation therapy for prostate cancer: Potential mechanisms
    Tivesten, Asa
    Pinthus, Jehonathan H.
    Clarke, Noel
    Duivenvoorden, Wilhelmina
    Nilsson, Jan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (11) : 464 - 475
  • [25] Androgen deprivation and immunotherapy for the treatment of prostate cancer
    Gamat, Melissa
    McNeel, Douglas G.
    ENDOCRINE-RELATED CANCER, 2017, 24 (12) : T297 - T310
  • [26] Androgen deprivation as a tumour-immunomodulating treatment
    Gamat-Huber, Melissa
    McNeel, Douglas G.
    NATURE REVIEWS UROLOGY, 2020, 17 (07) : 371 - 372
  • [27] Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients with prostate cancer? A nationwide population-based cohort study
    Kim, Do Kyung
    Lee, Hye Sun
    Park, Ju-Young
    Kim, Jong Won
    Ha, Ji Soo
    Kim, Jae Heon
    Yang, Won Jae
    Cho, Kang Su
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (04) : 1217 - 1226
  • [28] Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer
    Chung, S. D.
    Lin, H. C.
    Tsai, M. C.
    Kao, L. T.
    Huang, C. Y.
    Chen, K. C.
    ANDROLOGY, 2016, 4 (03) : 481 - 485
  • [29] Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective
    Teoh, Jeremy Yuen Chun
    Ng, Chi-Fai
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (09) : 1429 - 1435
  • [30] Impact of Androgen Deprivation on the Lipid Profile and Atherogenic Risk in Prostate Cancer Patients
    Salvador, C.
    Planas, J.
    Raventos, C.
    Ropero, J.
    Placer, J.
    Lopez, M. A.
    Morote, J.
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (04): : 205 - 209
12345